JH-003

N/A

Report date: 2025/03/07 20:00:40

NME

Base Information

Drug NameJH-003

Drug Alias NameJH-003

ClassificationSmall molecules > Synthetic peptideRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agent

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesBivision Biomedical Technology (Nanjing) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBivision Biomedical Technology (Nanjing) Co Ltd

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A